.jpg?format=webp&quality=80&width=3840)
In a study, concomitant transcatheter aortic valve replacement (TAVR) and left atrial appendage occlusion (LAAO) have shown non-inferiority to TAVR with medical therapy in atrial fibrillation (AF) patients with severe aortic stenosis. The study involving 349 patients revealed that TAVR+LAAO had a lower risk of all-cause mortality, stroke, and significant bleeding at two years compared to TAVR+medical therapy. Although the combined procedure is a promising alternative to anticoagulants for stroke prevention in AF patients undergoing TAVR, its increased complexity and risks should be carefully weighed.
Like
Save
Share